1. Berger, T. G., Dieckmann, D., Efferth, T., et al. (2011). Artesunate in the treatment of metastatic melanoma – Pilot study results. Cancer Chemotherapy and Pharmacology, 67(3), 703-707.
2. Dell’Eva, R., Pfeffer, U., Vene, R., et al. (2004). Inhibition of angiogenesis in vitro and in vivo by the anti-malarial artesunate. Biochemical Pharmacology, 68(12), 2359-2366.
3. Efferth, T., Dunstan, H., Sauerbrey, A., et al. (2007). The anti-malarial artesunate is also active against cancer. International Journal of Oncology, 30(6), 1287-1292.
4. Greene, S. A., Riggins, D. P., Hargrove, A. E., et al. (2018). Artesunate modulates immune responses and enhances anti-tumor immunity in experimental cancer models. Journal of Immunotherapy, 41(8), 385-393.
5. Zhang, S., Wang, J., Pan, J., et al. (2020). Artesunate enhances chemosensitivity in lung cancer by regulating apoptosis and autophagy. Cellular Physiology & Biochemistry, 54(1), 147-162.